Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Research graph
References from Tuberculosis Incidence and Predictors Among People Living With HIV After Isoniazid–Rifapentine (3HP) Preventive Therapy in Ethiopia: A Retrospective Cohort Study. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
2015 · External reference
Unresolved reference
2005 · External reference
Unresolved reference
2025 · External reference
Unresolved reference
2023 · External reference
Unresolved reference
External reference
Unresolved reference
2025 · External reference
National Tuberculosis and HIV Programmatic Management of LTBI
2020 · External reference
10.1186/s12889-019-7912-9
10.1186/s12889-019-7912-9 · External reference
Incidence and Predictors of Tuberculosis Occurrence Among Adults on Antiretroviral Therapy at Debra Markos Referral Hospital, Northwest Ethiopia: Retrospective Follow-Up Study
10.1186/s12879-020-04959-y · 2020 · External reference
10.1136/bmjopen-2017-016961
10.1136/bmjopen-2017-016961 · External reference
10.4178/epih.e2019028
10.4178/epih.e2019028 · External reference
10.1371/journal.pone.0232426
10.1371/journal.pone.0232426 · External reference
10.1016/j.ijid.2020.02.053
10.1016/j.ijid.2020.02.053 · External reference
10.1371/journal.pone.0272358
10.1371/journal.pone.0272358 · External reference
10.1186/1471-2334-13-292
10.1186/1471-2334-13-292 · External reference
10.1186/s40780-021-00228-5
10.1186/s40780-021-00228-5 · External reference
10.4236/aid.2016.62010
10.4236/aid.2016.62010 · External reference
Unresolved reference
2015 · External reference
Outcomes of the Three-Month Weekly Isoniazid With Rifapentine (3HP) Versus the Six-Month Isoniazid Preventive Therapy (6H) Among People Newly Enrolled in HIV Care in Western Kenya
10.1093/ofid/ofag416 · 2026 · External reference
10.5588/ijtld.21.0676
10.5588/ijtld.21.0676 · External reference
10.1186/s12879-023-08533-0
10.1186/s12879-023-08533-0 · External reference
10.1186/s41182-021-00306-2
10.1186/s41182-021-00306-2 · External reference
10.1016/j.cmi.2021.07.036
10.1016/j.cmi.2021.07.036 · External reference
10.1186/s12879-019-3696-x
10.1186/s12879-019-3696-x · External reference
10.1016/j.jiph.2021.09.009
10.1016/j.jiph.2021.09.009 · External reference
10.1371/journal.pone.0203986
10.1371/journal.pone.0203986 · External reference
10.11591/ijphs.v6i3.9294
10.11591/ijphs.v6i3.9294 · External reference
10.5588/ijtld.22.0012
10.5588/ijtld.22.0012 · External reference
10.1186/s12879-025-12353-9
10.1186/s12879-025-12353-9 · External reference
10.1016/s2213-2600(23)00096-6
10.1016/s2213-2600(23)00096-6 · External reference
10.1371/journal.pmed.1003738
10.1371/journal.pmed.1003738 · External reference
10.5588/ijtld.18.0168
10.5588/ijtld.18.0168 · External reference
10.1186/s12879-020-05290-2
10.1186/s12879-020-05290-2 · External reference
Prevalence and Associated Factors of hiv-tb Co-Infection Among Hiv Patients: A Retrospective Study
10.4314/ahs.v21i3.7 · 2021 · External reference